Indegene Ltd. (INDGN) fundamentals
Indegene Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as INDGN (ISIN INE065X01017). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Indegene Ltd. does
Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.
Valuation and market data
| Last close | ₹580.40 |
|---|---|
| Market capitalisation | ₹13,923 crore |
| Enterprise value | ₹14,018 crore |
| P/E (TTM) | 34.71 |
| Price to book | 4.44 |
| Price to sales (TTM) | 2.18 |
| Book value per share | ₹130.84 |
| Dividend yield | 38.77% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Mon May 13 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,299 crore | ₹281 crore | ₹212 crore | 8.83 |
| Mar 2025 | ₹1,184 crore | ₹239 crore | ₹181 crore | 7.64 |
| Mar 2024 | ₹1,096 crore | ₹181 crore | ₹138 crore | 6.22 |
| Mar 2023 | ₹1,043 crore | ₹177 crore | ₹130 crore | 5.89 |
| Mar 2022 | ₹865 crore | ₹170 crore | ₹133 crore | 6.05 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 0.0% |
|---|---|
| Foreign institutions (FII) | 9.9% |
| Mutual funds | 5.3% |
| Other domestic institutions | 3.5% |
| Retail and others | 81.3% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.